Parkinson's disease

BR Bloem, MS Okun, C Klein - The Lancet, 2021 - thelancet.com
Parkinson's disease is a recognisable clinical syndrome with a range of causes and clinical
presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; …

Genetics of Parkinson's disease: an introspection of its journey towards precision medicine

S Bandres-Ciga, M Diez-Fairen, JJ Kim… - Neurobiology of …, 2020 - Elsevier
ABSTRACT A substantial proportion of risk for Parkinson's disease (PD) is driven by
genetics. Progress in understanding the genetic basis of PD has been significant. So far …

The genetics of Parkinson's disease and implications for clinical practice

JO Day, S Mullin - Genes, 2021 - mdpi.com
The genetic landscape of Parkinson's disease (PD) is characterised by rare high penetrance
pathogenic variants causing familial disease, genetic risk factor variants driving PD risk in a …

Current therapies in clinical trials of Parkinson's disease: A 2021 update

EM Prasad, SY Hung - Pharmaceuticals, 2021 - mdpi.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder that currently has no
cure, but treatments are available to improve PD symptoms and maintain quality of life. In …

Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics

A Kulkarni, K Preeti, KP Tryphena, S Srivastava… - Ageing Research …, 2023 - Elsevier
The protein dyshomeostasis is identified as the hallmark of many age-related
neurodegenerative disorders including Parkinson's disease (PD). The diseased brain shows …

Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data

C Su, Y Hou, J Xu, Z Xu, M Zhou, A Ke, H Li, J Xu… - Npj Digital …, 2024 - nature.com
Parkinson's disease (PD) is a serious neurodegenerative disorder marked by significant
clinical and progression heterogeneity. This study aimed at addressing heterogeneity of PD …

[HTML][HTML] Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments

ME Gegg, E Menozzi, AHV Schapira - Neurobiology of Disease, 2022 - Elsevier
Dysfunction of the endolysosomal system is implicated in the pathogenesis of both sporadic
and familial Parkinson disease (PD). Variants in genes encoding lysosomal proteins have …

New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin

K Senkevich, U Rudakou, Z Gan-Or - Neuropharmacology, 2022 - Elsevier
Parkinson's disease (PD) is defined as a complex disorder with multifactorial pathogenesis,
yet a more accurate definition could be that PD is not a single entity, but rather a mixture of …

Dysfunction of cellular proteostasis in Parkinson's disease

Š Lehtonen, TM Sonninen, S Wojciechowski… - Frontiers in …, 2019 - frontiersin.org
Despite decades of research, current therapeutic interventions for Parkinson's disease (PD)
are insufficient as they fail to modify disease progression by ameliorating the underlying …

[HTML][HTML] The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches

A Drobny, SP Huarcaya, J Dobert, A Kluge… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Lysosomes are ubiquitous organelles with a fundamental role in maintaining cellular
homeostasis by mediating degradation and recycling processes. Cathepsins are the most …